Table 1.
Baseline Characteristics of Patients Received DeVIC Therapy (n=36)
| N=36 | ||
|---|---|---|
| Sex, number (%) | Male | 16 (44) |
| Female | 20 (56) | |
| Age (years), median (IQR) | 72 (64-75) | |
| Treatment line, number (%) | First line | 3 (8) |
| Second line or more | 33 (92) | |
| Dose (mg/m2), median (IQR) | Ifosfamide | 1,192 (1,089-1,414) |
| Etoposide | 81 (73-98) | |
| Carboplatine | 238 (218-295) | |
| Body surface area (m2), median (IQR) | 1.53 (1.44-1.68) | |
| Renal function before administration, median (IQR) | Ccr (mL/min) | 56 (45-68) |
| Blood cell count before administration, median (IQR) | Neutrophil (×103 /μL) | 3.58 (2.80-4.81) |
| Hemoglobin (μg/dL) | 11.1 (9.9-11.9) | |
| Platelet (×104 /μL) | 21.7 (15.3-31.6) |
Abbreviation: interquartile range; IQR, creatinine clearance; Ccr